We are live on ! Find out more
CCM

Concord Medical Services

4 hedge funds and large institutions have $77.2K invested in Concord Medical Services in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more capital invested

Capital invested by funds: $26K → $77.2K (+$51.1K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more funds holding

Funds holding: 34 (+1)

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$37.1K -$1.07K -160 -4%
RhumbLine Advisers
2
RhumbLine Advisers
Massachusetts
$18.9K +$9.65K +1,440 +264%
XT
3
XTX Topco
Cayman Islands
$13.4K +$9.45K +1,410 New
UBS Group
4
UBS Group
Switzerland
$7.75K +$5.47K +816 New
Bank of America
5
Bank of America
North Carolina
-$14 -3 Closed

CCM Hedge Fund Activity: Q2 2024 in Review

4 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q2 2024, worth a combined $77.2K — up 196% from $26K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CCM positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was RhumbLine Advisers, adding an estimated $9.65K. The largest seller was Renaissance Technologies, cutting an estimated $1.07K.

  • 4 institutional investors held Concord Medical Services (CCM) as of Q2 2024, up from 3 in Q1 2024.
  • Funds reported $77.2K of Concord Medical Services stock for Q2 2024, up 196% quarter-over-quarter.
  • 2 funds opened new Concord Medical Services positions in Q2 2024 and 1 closed out, a net change of +1 holder.
  • The largest Concord Medical Services buyer in Q2 2024 was RhumbLine Advisers, an estimated $9.65K added.
  • The largest Concord Medical Services seller in Q2 2024 was Renaissance Technologies, an estimated $1.07K sold.

Based on aggregated 13F filings for Q2 2024.